IMR Press / RCM / Volume 24 / Issue 10 / DOI: 10.31083/j.rcm2410288
Open Access Review
Targeting Autophagy in Atrial Fibrillation
Show Less
1 Department of Cardiology, The Affiliated Hospital of Southwest Medical University, 646000 Luzhou, Sichuan, China
*Correspondence: art006023@yeah.net (Qiang Ye); zha_kelan@outlook.com (Kelan Zha)
Rev. Cardiovasc. Med. 2023, 24(10), 288; https://doi.org/10.31083/j.rcm2410288
Submitted: 17 November 2022 | Revised: 4 May 2023 | Accepted: 19 May 2023 | Published: 8 October 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Atrial fibrillation (AF) is the most common type of arrhythmia in clinical practice, and its incidence is positively correlated with risk factors that include advanced age, hypertension, diabetes, and heart failure. Although our understanding of the mechanisms that govern the occurrence and persistence of AF has been increasing rapidly, the exact mechanism of AF is still not fully understood. Autophagy is an evolutionarily highly conserved and specific physiological process in cells that has been suggested as a potential therapeutic target for several cardiovascular diseases including the pathophysiology of AF. The present article provides an updated review of the fast-progressing field of research surrounding autophagy in AF, and how regulating autophagy might be a therapeutic target to reduce the incidence of AF.

Keywords
atrial anatomical remodeling
atrial electrical remodeling
atrial fibrillation
autophagy
energy metabolism remodeling
Funding
S22091/Medical Research project of Sichuan Province
S21111/Medical Research project of Sichuan Province
Figures
Fig. 1.
Share
Back to top